Peter Kim recently took the opportunity of welcoming newly-acquired social business consultancy Headshift to the Dachis Group (itself ‘created to unlock the value of social technologies for large corporate enterprises’) to restate of the foundations of social business design as they perceive it:
- business partner organization
- workforce collaboration
- customer participation.
The people who can make the biggest difference to your company don’t work for it. Adapting to the network means they can[…] If there is a part of your business that can’t be disrupted by adhoc communities of purpose (forming online to improve on what you currently do) you are in an extremely enviable position.
Dachis offers a contemporary, persuasive take on the contemporary business environment with a number of heavy-hitting opinion leaders on their bench. I should imagine that every business who engages their services will conclude that they have added significant value to their enterprise.
However, whilst Dachis count a number of health care brands among their roster of clients, they can’t work with everyone.
It would seem to me that with the resources they are capable of marshaling, most pharma companies could heal a number of the afflictions that ail them by self-medicating with the principles of social business design.
It’s time to go beyond buffing your Twitter account, cultivating your Facebook page, sorting your StumbleUpon links, and tuning in your YouTube channel.
In short, it’s time to redesign your marketing strategies using the precepts of social business design.
- View your B2B associates as partners, not vendors.
- Design, implement, and make colleagues take personal responsibility for and ownership of an effective social media governance policy for internal and external use.
- Finally, and most importantly for your purposes, participate with your customers in an authentic, transparent way.
Defining who your customers are depends on where you’re doing business, of course, but I am going to define this as the patient.
Personalized medicine, patient health records, patient activism and advocacy are going to drive change in health care.
The challenge facing any given pharma company is to redesign its business to be able to meet patients where they want to find it.
Which channels are you going to choose?